Maureen E Morgan, MD
Gastroenterology · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Morgan’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A101842 · Current
Licensed to practise in California · since 2007 · expires 2027-07-31 · Oregon Health Sciences University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$2,204
Medicare paid this office $2,204 for 14 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
14 Original Medicare patients in 2024. Average age 69 · Health risk score 1.85. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75%.
The office billed $10,765, Medicare allowed $3,169 and paid $2,204; for 21 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 14 | 21 | 69 | 1.85 | $10,765 | $2,204 |
| 2023 | 16 | 27 | 71 | 2.22 | $19,462 | $4,301 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$331,249
Pharmacies billed $331,249 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
743 generic and fewer than 11 brand-name prescriptions · $331,249 in drug cost · 86 antibiotic prescriptions to 31 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 31 | $95,525 | $3,081 |
| Creon | 37 | $89,823 | $2,428 |
| Mesalamine | 40 | $18,647 | $466 |
| Linzess | 20 | $15,035 | $752 |
| Motegrity | 17 | $11,876 | $699 |
See all 20 drugs
| Xifaxan | 31 | $95,525 | $3,081 |
| Creon | 37 | $89,823 | $2,428 |
| Mesalamine | 40 | $18,647 | $466 |
| Linzess | 20 | $15,035 | $752 |
| Motegrity | 17 | $11,876 | $699 |
| Trulance | 17 | $9,591 | $564 |
| Gavilyte-C | 169 | $3,958 | $23 |
| Ursodiol | 16 | $3,531 | $221 |
| Budesonide Dr | 28 | $3,186 | $114 |
| Pantoprazole | 190 | $2,658 | $14 |
| Cholestyramine | 11 | $860 | $78 |
| Sucralfate | 14 | $837 | $60 |
| Omeprazole | 46 | $561 | $12 |
| Esomeprazole Magnesium | 18 | $518 | $29 |
| Rabeprazole | 14 | $464 | $33 |
| Diphenoxylate-Atropine | 18 | $432 | $24 |
| Prednisone | 14 | $224 | $16 |
| Metronidazole | 18 | $167 | $9 |
| Famotidine | 15 | $152 | $10 |
| Metoclopramide | 11 | $101 | $9 |
Year by year
| 2024 | 947 | 354 | None | None | $331,249 |
| 2023 | 887 | 318 | None | None | $376,891 |
| 2022 | 770 | 290 | None | None | $359,411 |
| 2021 | 716 | 241 | 0% (0) | None | $366,937 |
| 2020 | 598 | 202 | None | None | $281,111 |
| 2019 | 596 | 258 | 0% (0) | 27% | $267,625 |
| 2018 | 608 | 299 | None | 39% | $202,060 |
| 2017 | 443 | 235 | None | 27% | $180,913 |
| 2016 | 355 | 164 | 0% (0) | 23% | $122,538 |
| 2015 | 447 | 252 | None | 17% | $93,558 |
| 2014 | 350 | 205 | 0% (0) | 21% | $67,260 |
| 2013 | 71 | 56 | 0% (0) | None | $3,346 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Xifaxan | 36 | $125,501 | $3,486 |
| Creon | 38 | $103,499 | $2,724 |
| Linzess | 33 | $20,535 | $622 |
| Motegrity | 32 | $19,127 | $598 |
| Lialda | 23 | $12,612 | $548 |
| Trulance | 18 | $7,981 | $443 |
| Budesonide Dr | 35 | $4,125 | $118 |
| Ursodiol | 18 | $3,774 | $210 |
| Gavilyte-C | 158 | $3,236 | $20 |
| Pantoprazole | 188 | $2,774 | $15 |
| Mesalamine | 14 | $1,783 | $127 |
| Hydrocortisone | 18 | $1,418 | $79 |
| Sucralfate | 11 | $901 | $82 |
| Diphenoxylate-Atropine | 17 | $723 | $43 |
| Esomeprazole Magnesium | 18 | $436 | $24 |
| Rabeprazole | 19 | $387 | $20 |
| Prednisone | 15 | $239 | $16 |
| Omeprazole | 14 | $191 | $14 |
| Ondansetron Odt | 14 | $146 | $10 |
2022: 17 drugs
| Xifaxan | 21 | $74,443 | $3,545 |
| Creon | 26 | $74,038 | $2,848 |
| Motegrity | 38 | $25,318 | $666 |
| Linzess | 17 | $14,652 | $862 |
| Lialda | 26 | $13,797 | $531 |
| Sucralfate | 33 | $3,885 | $118 |
| Budesonide Dr | 27 | $3,292 | $122 |
| Budesonide Ec | 16 | $2,466 | $154 |
| Pantoprazole | 149 | $2,341 | $16 |
| Gavilyte-C | 97 | $1,721 | $18 |
| Hydrocortisone | 14 | $1,090 | $78 |
| Esomeprazole Magnesium | 23 | $1,086 | $47 |
| Diphenoxylate-Atropine | 30 | $1,028 | $34 |
| Cholestyramine | 13 | $958 | $74 |
| Peg-3350 and Electrolytes | 35 | $683 | $20 |
| Prednisone | 20 | $367 | $18 |
| Ondansetron Odt | 14 | $350 | $25 |
2021: 18 drugs
| Creon | 29 | $80,255 | $2,767 |
| Xifaxan | 33 | $79,238 | $2,401 |
| Linzess | 28 | $21,310 | $761 |
| Motegrity | 31 | $19,194 | $619 |
| Lialda | 24 | $13,056 | $544 |
| Sucralfate | 23 | $5,086 | $221 |
| Budesonide Ec | 26 | $4,401 | $169 |
| Pantoprazole | 108 | $1,986 | $18 |
| Diphenoxylate-Atropine | 30 | $1,317 | $44 |
| Esomeprazole Magnesium | 20 | $1,064 | $53 |
| Cholestyramine | 14 | $980 | $70 |
| Promethegan | 11 | $922 | $84 |
| Azathioprine | 14 | $822 | $59 |
| Peg-3350 and Electrolytes | 40 | $810 | $20 |
| Gavilyte-C | 43 | $645 | $15 |
| Omeprazole | 14 | $304 | $22 |
| Prednisone | 12 | $303 | $25 |
| Ondansetron Odt | 16 | $285 | $18 |
2020: 16 drugs
| Creon | 33 | $85,739 | $2,598 |
| Humira | 11 | $45,656 | $4,151 |
| Xifaxan | 21 | $44,900 | $2,138 |
| Linzess | 20 | $12,455 | $623 |
| Mesalamine | 21 | $6,967 | $332 |
| Lialda | 11 | $6,673 | $607 |
| Motegrity | 13 | $6,475 | $498 |
| Budesonide Ec | 31 | $4,030 | $130 |
| Diphenoxylate-Atropine | 30 | $1,700 | $57 |
| Pantoprazole | 82 | $1,610 | $20 |
| Azathioprine | 17 | $1,192 | $70 |
| Gavilyte-C | 49 | $985 | $20 |
| Lactulose | 11 | $594 | $54 |
| Dicyclomine | 15 | $390 | $26 |
| Omeprazole | 18 | $377 | $21 |
| Peg-3350 and Electrolytes | 17 | $367 | $22 |
2019: 13 drugs
| Creon | 19 | $60,546 | $3,187 |
| Xifaxan | 28 | $54,818 | $1,958 |
| Humira | 13 | $52,662 | $4,051 |
| Zenpep | 11 | $31,947 | $2,904 |
| Lialda | 13 | $13,602 | $1,046 |
| Budesonide Ec | 47 | $5,819 | $124 |
| Gavilyte-C | 136 | $4,913 | $36 |
| Diphenoxylate-Atropine | 26 | $2,051 | $79 |
| Pantoprazole | 78 | $1,565 | $20 |
| Lactulose | 14 | $678 | $48 |
| Ondansetron Odt | 15 | $398 | $27 |
| Dicyclomine | 16 | $272 | $17 |
| Omeprazole | 13 | $219 | $17 |
2018: 14 drugs
| Humira | 13 | $50,725 | $3,902 |
| Creon | 17 | $42,476 | $2,499 |
| Xifaxan | 19 | $32,422 | $1,706 |
| Budesonide Ec | 40 | $8,852 | $221 |
| Gavilyte-C | 85 | $3,077 | $36 |
| Peg 3350-Electrolyte | 74 | $2,679 | $36 |
| Diphenoxylate-Atropine | 24 | $2,272 | $95 |
| Pantoprazole | 68 | $1,661 | $24 |
| Gavilyte-G | 19 | $446 | $23 |
| Prednisone | 12 | $349 | $29 |
| Omeprazole | 12 | $249 | $21 |
| Ondansetron | 16 | $223 | $14 |
| Dicyclomine | 11 | $144 | $13 |
| Metronidazole | 11 | $109 | $10 |
2017: 9 drugs
| Humira | 12 | $44,327 | $3,694 |
| Creon | 20 | $39,189 | $1,959 |
| Budesonide Ec | 42 | $35,071 | $835 |
| Xifaxan | 15 | $23,989 | $1,599 |
| Carafate | 14 | $8,153 | $582 |
| Gavilyte-C | 165 | $2,805 | $17 |
| Diphenoxylate-Atropine | 14 | $1,612 | $115 |
| Pantoprazole | 56 | $1,244 | $22 |
| Ondansetron | 20 | $363 | $18 |
2016: 9 drugs
| Humira | 13 | $43,666 | $3,359 |
| Budesonide Ec | 22 | $20,360 | $925 |
| Xifaxan | 11 | $17,288 | $1,572 |
| Carafate | 15 | $7,099 | $473 |
| Gavilyte-C | 98 | $1,690 | $17 |
| Pantoprazole | 65 | $1,620 | $25 |
| Cholestyramine | 17 | $1,393 | $82 |
| Diphenoxylate-Atropine | 11 | $900 | $82 |
| Prednisone | 11 | $374 | $34 |
2015: 7 drugs
| Humira | 13 | $33,911 | $2,609 |
| Budesonide Ec | 14 | $13,138 | $938 |
| Carafate | 25 | $10,927 | $437 |
| Gavilyte-C | 194 | $3,310 | $17 |
| Pantoprazole | 73 | $2,004 | $27 |
| Cholestyramine | 14 | $955 | $68 |
| Lactulose | 34 | $683 | $20 |
2014: 6 drugs
| Carafate | 18 | $6,483 | $360 |
| Gavilyte-C | 142 | $2,474 | $17 |
| Diphenoxylate-Atropine | 12 | $994 | $83 |
| Pantoprazole | 30 | $813 | $27 |
| Omeprazole | 17 | $434 | $26 |
| Peg 3350-Electrolyte | 13 | $221 | $17 |
2013: 1 drug
| Gavilyte-C | 47 | $823 | $18 |
Professional record
- NPI
- 1093998809
- Licence
- CA A101842California A101842: Current · expires 2027-07-31
- Trained
- Oregon Health Sciences University School of Medicine, 2006
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Internal Med, San Jose, CA, 95128
- NPI first listed
- 2007-12-14
- NPI last updated
- 2021-12-22
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.